目的评价介入治疗对不同类型原发性肝癌的疗效。方法介入化疗栓塞(TACE)治疗原发性肝癌360例,其中,结节型167例,巨块型92例,弥漫型101例。而根据不同类型采用化疗+栓塞和单纯灌注化疗的治疗方式。结果结节型3年生存率25.7%,巨块型3年生存率23.9%,弥漫型3年生存率为0%。结论结节型和巨块型肝癌采用化疗栓塞方法治疗,对患者延长生存时间是有效的,而弥漫型肝癌仅在短时间内改善生存质量有一定的作用。 Objective To evaluate the effect of interventional therapy on different types of primary liver cancer. Methods Interventional chemotherapy embolization (TACE) for the treatment of primary liver cancer in 360 cases, of which 167 cases of nodular, bulky 92 cases, diffuse 101 cases. According to different types of chemotherapy + embolization and simple perfusion chemotherapy treatment. Results Nodular 3-year survival rate was 25.7%, massive 3-year survival rate was 23.9%, and diffuse 3-year survival rate was 0%. Conclusions Nodular and massive hepatocellular carcinoma is treated by chemotherapy and embolization, which is effective in prolonging the survival time of patients. Diffuse hepatocellular carcinoma only plays a role in improving quality of life in a short period of time.